LienTeh.net > Ads > Vebreltinib (Bozitinib)

Vebreltinib (Bozitinib)

Inquire / Price

Model Number：

RL3220250101
Brand Name：

万比锐
Origin：

Original invention from China
Small Orders：

Small batches also available
Tags：

Brain Tumor. Lung Cancer

Inquire Now Link

Poster

Details
Description

Packaging Size

60c/Box
Strength

100mg
Compositon

Vebreltinib
Treatment

MET Exon 14+ NSCLC, MET Fusion+ Glioma
Form

Capsule
Brand

万比锐
Quantity Unit

100mg*60c/box
Manufacturer

Avistone Biotechnology,china

About Vebreltinib

Vebreltinib (also known as bozitinib) is a pharmaceutical drug used for the treatment of cancer . Vebreltinib selectively binds to c-Met, preventing its phosphorylation and thereby disrupting c-Met signal transduction pathways.

Vebreltinib sold as brand name 万比锐® in china.

China’s National Medical Products Administration (NMPA) has granted conditional marketing approval to vebreltinib (APL-101; PBL-1001) for the treatment of patients with non–small cell lung cancer (NSCLC) harboring MET exon 14 skipping mutations.

China’s National Medical Products Administration (NMPA) has approved vebreltinib (APL-101; PLB-1001) for the treatment of patients with IDH-mutant, World Health Organization grade 4 astrocytoma or glioblastoma who harbor PTPRZ1-MET (ZM) fusions, have a history of low-grade disease, and have progressed on prior treatments.